Association of serum adiponectin with risk for cardiovascular events in patients with peripheral arterial disease

Keyphrases

• Cardiovascular Events 100%
• Peripheral Arterial Disease 100%
• Serum Adiponectin 100%
• Non-fatal Cardiovascular Events 85%
• All-cause Mortality 71%
• Previous Myocardial Infarction 42%
• Adiponectin 28%
• Ankle-brachial Index 28%
• Multivariable Model 28%
• Beta-blockers 14%
• Male Patients 14%
• Type 1 Diabetes Mellitus (T1DM) 14%
• Cox Regression 14%
• Relative Risk 14%
• Cox Regression Analysis 14%
• Statistical Significance 14%
• Cholesterol 14%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 14%
• Smoking Status 14%
• Immunoassay 14%
• Antiatherogenic 14%
• Anti-inflammatory Properties 14%
• Systemic Hypertension 14%
• Leg Ischemia 14%
• Total Adiponectin 14%
• Biomarker for Cardiovascular Disease 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Adiponectin 100%
• Peripheral Occlusive Artery Disease 100%
• Cause of Death 40%
• Heart Infarction 30%
• Beta Adrenergic Receptor Blocking Agent 10%
• Cardiovascular Disease 10%
• Symptom 10%
• Biological Marker 10%
• All Cause Mortality 10%
• Diabetes Mellitus 10%
• Hypertension 10%
• Immunoassay 10%
• Dipeptidyl Carboxypeptidase Inhibitor 10%
• Anti-Inflammatory Drug 10%
• Leg Ischemia 10%

Biochemistry, Genetics and Molecular Biology

• Adiponectin 100%
• Beta Blocker 10%
• Angiotensin-Converting Enzyme 10%
• All Cause Mortality 10%
• Cholesterol Blood Level 10%
• Immunoassay 10%
• Enzyme Inhibitor 10%